Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.1
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating Expenses    
General And Administrative $ 1,482 $ 1,389
Research And Development 464 307
Total Operating Expenses 1,946 1,696
Loss From Operations (1,946) (1,696)
Other Income    
Interest Income 1 0
Net Change In Fair Value Of Marketable Securities (20) 1
Total Other (expense) Income (19) 1
Provision For Income Taxes 0 0
Net Loss (1,965) (1,695)
Other Comprehensive Income (loss)    
Net Unrealized Loss Of Available-for-sale Securities (22) 0
Foreign Currency Translation Adjustments (24) 2
Total Other Comprehensive Income (loss) (46) 2
Total Comprehensive Loss $ (2,011) $ (1,693)
Basic And Diluted Loss Per Common Share $ (0.05) $ (0.09)
Basic And Diluted Weighted Average Common Shares Outstanding 42,301 19,688